Australia Migraine Drugs Market Analysis


  • Type: Common Disease Area
  • Published : April 2021
  • Region: APAC
  • Country: Australia
  • Report ID : 4129

  • Format: PPT, PDF

Australian Migraine Drugs Market: Segmented by Drug Class (Abortive Medicine (Triptans, Ergots, & Others), & Preventive Medicine (Anticonvulsant, Antidepressant, Beta Blocker, & Others)), by Route of Administration (Oral, Parenteral, & Others), by Distribution Channel (Hospital Pharmacies, Online Pharmacies, & Others)- Growth, Trends, and Forecast (2019 – 2028)


Report Overview

The Australian Migraine Drugs market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Migraine is a neurological condition that is estimated to affect 4.9 million Australians. Migraine is characterized by recurrent attacks of moderate to severe headache. Migraine pain is typically pulsating, affecting one side or area of the head. During a migraine attack, patients may experience nausea, vomiting, and sensory sensitivity such as phonophobia and photophobia that significantly affects their lives. Despite its impact, migraine is underdiagnosed and undertreated. The total economic costs of migraines in 2018 are estimated to be $35.7 billion in 2018. $8.1 billion (23%) of these costs are attributable to chronic migraine and $27.6 billion (77%) are attributable to episodic migraine.

Market Drivers

The rise in prevalence of migraine and the development of novel drugs are the major drivers which propelled the demand of the market in the forecast period. The rising population and growing demand for quality drugs are significant factors driving the growth of the global migraine drugs market. Creating awareness over the availability of different treatment procedures for migraines in rural areas boosts the demand of the market. Investments in the development of new drugs by market players and other companies are also leveling up the growth rate of the market. Changes in lifestyles and rising stress levels among people are some of the factors for the market to grow.


20.55% of Australians suffer from migraines. Prevalence is higher for women, with 28.66% of women experiencing migraines compared to 11.96% of men (Institute for Health Metrics Evaluation (IHME), 2016). 7.6% of Australian migraine sufferers experience a severe form of migraine known as chronic migraine, defined as 15 or more migraine days per month.

Females aged 25 to 29 face the highest prevalence rate of chronic migraine (3.7% of this cohort), while the highest prevalence rate of episodic migraine (42.3%) occurs in females aged 35 to 39. Migraine prevalence (rate and cases) is higher among females than males in every age group, and prevalence (rate and cases) for males is more stable across age groups. 86% of people with migraines are of working age (15-65).

1. Australian Migraine Drugs Market Overview……………………………………………………
A. Market Size
2. Market Growth Drivers…………………………………………….……………………….
A. Rising prevalence of migraine
B. development of novel drugs
C. Growing R&D Investments and Reimbursement Policies
3. Epidemiology………………….…………………………………………………….….…
A. Prevalence by Gender
B. Prevalence by Age
4. Migraine Drugs Market Segmentation……………………………………………………………..
A. Drug Class
I. Abortive Medicine
a. Triptans
b. Ergots
c. Others
II. Preventive Medicine
a. Anticonvulsant
b. Antidepressant
c. Beta Blocker
d. Others
B. Route of Administration
I. Oral
II. Parenteral
III. Others
C. Distribution Channel
I. Hospital Pharmacies
II. Online Pharmacies
III. Others
5. Migraine Major Products Market Share………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………….………….…………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………….
A. Eli Lilly and Company Company overview, Product & Services, Strategies & Financials
B. Abbott Company overview, Product & Services, Strategies & Financials
C. GlaxoSmithKline Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape………………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………………
A. New Trends and Development of Migraine Drugs Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug Class:

Based on drug class, the Australian migraine drugs market is segmented into abortive medicine (which is further sub-segmented into triptans, ergots, and others) and preventive medicines which is further sub-segmented into anticonvulsant, antidepressant, beta-blockers, and others). Triptans are a class of medications used to treat acute migraine attacks – that is, the part of your migraine attack where symptoms are most severe, for many people the headache part of the attack. Acute medications are designed to stop a migraine attack as the attack begins. Triptans cannot prevent your attack but can help alleviate the symptoms of migraine attacks such as pain, nausea, and sensitivity to light and sound.

By Route of Administration:

Based on the route of administration, the market is segmented into oral, parenteral, and others. An oral segment is expected to dominate the market as most of the available drugs used for migraine treatment are available in tablet forms, as oral route is used most often as it is considered safest, convenient, and least expensive.

By Distribution Channel:

Based on the distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. The hospital pharmacies segment is expected to dominate the market as hospitals are the primary source from where drugs can be procured by patients.

Major Players

Migraine treatment market competitive landscape provides details by the competitor. The major players covered in the report are Amgen Inc., Eli Lilly, and Company, GlaxoSmithKline plc., Novartis AG, Bayer AG, Allergan, Abbott, AstraZeneca, Bausch Health Companies Inc, Catalent, Inc, Dr. Reddy’s Laboratories Ltd., Lundbeck, Merck Sharp & Dohme Corp (A Subsidiary of Merck & Co., Inc.), Pfizer Inc., Otsuka Pharmaceutical Co., Ltd (A Subsidiary of Otsuka Holdings Co., Ltd.), Sun Pharmaceutical Industries Ltd, among others.

In November 2019, REYVOW a product developed by Eli Lily and company has received FDA approval for acute migraine treatment. This product approval has increased the company’s solution for migraine treatment and hence helped it to enhance its revenue by increasing its product sales.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements